Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Sinclair Pharmaceuticals, Ltd. — Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

104 daysmedian FDA review time
624 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K050158SINCLAIR SEBORRHEA EMULSIONSinclair Pharmaceuticals, Ltd.2006-10-116240
K042722ALOCLAIR ORAL SPRAYSinclair Pharmaceuticals, Ltd.2005-01-131040
K040950ALOCLAIR ORAL GELSinclair Pharmaceuticals, Ltd.2004-06-21700
K024148SALINUM, ORCLAIRSinclair Pharmaceuticals, Ltd.2003-09-152730
K024367SINCLAIR WOUND AND SKIN EMULSIONSinclair Pharmaceuticals, Ltd.2003-07-282090
K023046SST SALIVA SUPPORTING TABLETSSinclair Pharmaceuticals, Ltd.2002-12-02810
K023155ALOCLAIR ORAL RINSESinclair Pharmaceuticals, Ltd.2002-11-25630
K013056GELCLAIR CONCENTRATED ORAL GELSinclair Pharmaceuticals, Ltd.2001-12-211010

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda